In addition, other studies have reported SRC-2 and SRC-3 overexpression in 50 and 40% of uterine fibroid cases, respectively, compared with adjacent myometrium, suggesting a potential pathological role for these coactivators in fibroid development (41). The gene discussed is NCOA3; the disease is uterine corpus leiomyoma.